4//SEC Filing
Winkler Sarah Hollis 4
Accession 0001487371-21-000024
CIK 0001487371other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:36 PM ET
Size
13.0 KB
Accession
0001487371-21-000024
Insider Transaction Report
Form 4
Winkler Sarah Hollis
VP, Human Resources
Transactions
- Exercise/Conversion
Common Stock
2021-01-21+10,845→ 135,021 total - Exercise/Conversion
Common Stock
2021-01-21+16,666→ 151,687 total - Sale
Common Stock
2021-01-25$14.22/sh−10,317$146,708→ 141,370 total - Exercise/Conversion
Market Stock Units
2021-01-21−10,845→ 3,333 totalExercise: $0.00→ Common Stock (10,845 underlying) - Exercise/Conversion
Market Stock Units
2021-01-21−16,666→ 16,667 totalExercise: $0.00→ Common Stock (16,666 underlying)
Footnotes (4)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units.
- [F2]The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index.
- [F3]Represents the target number of shares which remain subject to the award.
- [F4]The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index.
Documents
Issuer
GenMark Diagnostics, Inc.
CIK 0001487371
Entity typeother
Related Parties
1- filerCIK 0001776182
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 8:36 PM ET
- Size
- 13.0 KB